Physician profile
Brooklyn Lowe
NPI 1306692157
$1,275.21
in general payments reported to CMS, 2019-2025
14 companies · $1,216 in 2025
The $1,216 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $59.04 · 2025: $1,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,275.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $242.68 | 2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $229.78 | 2024-2025 | |
| Janssen Biotech, INC. | $163.75 | 2025 | Tremfya |
| Abbvie INC. | $159.62 | 2025 | |
| Novartis Pharmaceuticals Corporation | $144.97 | 2024-2025 | |
| Genzyme Corporation | $127.55 | 2025 | |
| Incyte Corporation | $56.91 | 2025 | Opzelura |
| Galderma Laboratories, L.P. | $33.16 | 2025 | Nemluvio |
| Kyowa Kirin, INC. | $24.29 | 2025 | |
| Mayne Pharma Commercial LLC | $22.76 | 2025 | |
| Amgen INC. | $21.13 | 2025 | Otezla |
| Ucb, INC. | $17.16 | 2025 | Bimzelx |
| Lnhc, INC | $16.82 | 2025 | Zelsuvmi |
| Lilly USA, LLC | $14.63 | 2025 | Ebglyss, Taltz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooklyn Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.